Many future scientific breakthroughs will result from the use of new technologies. As a result, the medicines of tomorrow will be different from those of today. We aim to develop new medicines that do more than just slow the progress of a disease or add a few months to a patient’s life. We are on a quest to transform and, ultimately, cure the disease.
To get there, we need to be able to target any novel biology we uncover. That’s why we are making our drug platforms more diverse, expanding beyond the traditional small molecules, monoclonal antibodies and peptides.
Advancements in biotechnology have expanded our toolkit of drug modalities. This provides an opportunity to design therapeutics for disease mechanisms previously considered difficult, if not impossible, to target and enables our scientists to pioneer new approaches to drug discovery.
We partner with others around the world, combining the great science in our labs with complementary technologies, know-how and molecules to accelerate the delivery of new life-changing medicines.
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.